ZA202205263B - Solid pharmaceutical forms of perampanel - Google Patents
Solid pharmaceutical forms of perampanelInfo
- Publication number
- ZA202205263B ZA202205263B ZA2022/05263A ZA202205263A ZA202205263B ZA 202205263 B ZA202205263 B ZA 202205263B ZA 2022/05263 A ZA2022/05263 A ZA 2022/05263A ZA 202205263 A ZA202205263 A ZA 202205263A ZA 202205263 B ZA202205263 B ZA 202205263B
- Authority
- ZA
- South Africa
- Prior art keywords
- perampanel
- solid pharmaceutical
- pharmaceutical forms
- forms
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20210100360A GR1010285B (en) | 2021-05-31 | 2021-05-31 | Solid pharmaceutical forms of perampanel |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202205263B true ZA202205263B (en) | 2023-01-25 |
Family
ID=83192224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2022/05263A ZA202205263B (en) | 2021-05-31 | 2022-05-12 | Solid pharmaceutical forms of perampanel |
Country Status (2)
Country | Link |
---|---|
GR (1) | GR1010285B (en) |
ZA (1) | ZA202205263B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY148809A (en) * | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
WO2009054544A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists for parkinson's disease and movement disorders |
EP2800747A4 (en) * | 2012-01-03 | 2015-12-09 | Mapi Pharma Ltd | Polymorphs of perampanel |
CN106389367B (en) * | 2016-11-16 | 2020-12-18 | 杭州朱养心药业有限公司 | Perampanel coated tablet pharmaceutical composition |
-
2021
- 2021-05-31 GR GR20210100360A patent/GR1010285B/en active IP Right Grant
-
2022
- 2022-05-12 ZA ZA2022/05263A patent/ZA202205263B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GR1010285B (en) | 2022-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279464A (en) | Pharmaceutical formulation of odevixibat | |
EP3914252A4 (en) | Pharmaceutical compositions of nilotinib | |
IL286218A (en) | Solid state forms of ripretinib | |
GB202008961D0 (en) | Pharmaceutical composition | |
ZA202203770B (en) | Pharmaceutical combination of prmt5 inhibitors | |
EP4098258A4 (en) | Pharmaceutical use of ketoamide-based compound | |
GB202020191D0 (en) | Pharmaceutical compounds | |
IL279622A (en) | Pharmaceutical formulations of masked antibodies | |
IL283286A (en) | Pharmaceutical formulations of cyclosporine analogs | |
IL304354A (en) | Solid tablet dosage form of ridinilazole | |
GB202010409D0 (en) | Pharmaceutical compounds | |
ZA202205263B (en) | Solid pharmaceutical forms of perampanel | |
EP4076442A4 (en) | Pharmaceutical composition of cyclooxygenase - 2 inhibitors | |
GB202010408D0 (en) | Pharmaceutical compounds | |
GB202103774D0 (en) | Detectiion of Ransomware | |
IL311716A (en) | Pharmaceutical composition of sepiapterin | |
GB202117969D0 (en) | Pharmaceutical compounds | |
GB202111193D0 (en) | Pharmaceutical compounds | |
GB202104097D0 (en) | Pharmaceutical compounds | |
GB202102602D0 (en) | Pharmaceutical compounds | |
GB202007163D0 (en) | Pharmaceutical compounds | |
GB202003646D0 (en) | Pharmaceutical compounds | |
GB202002144D0 (en) | Pharmaceutical compounds | |
KR102423280B9 (en) | Sot-mram area-optimized design of sot-mram | |
GB202304987D0 (en) | Combination pharmaceutical |